Surbhi Singh: Incidental Thrombocytopenia May Sometimes Be the First Clue to an Underlying Hematological Malignancy
Surbhi Singh, Consultant Haematopathology at Agilus Diagnostics and Fortis Hospital Gurugram, shared a post on LinkedIn:
“Incidental thrombocytopenia may sometimes be the first clue to an underlying hematological malignancy, highlighting the importance of not overlooking seemingly minor hematological abnormalities.
A 74 year old male presented with incidental finding of thrombocytopenia and monocytosis on CBC (Fig. 1).
PS revealed AMC 2560/uL and platelet count of 60k/uL. Bone marrow aspirate revealed myeloid preponderance with increase in monocytes and no increase in blasts, few dyspoeitic megakaryocytes (~12%) Fig.2, s/o CMML .
Flowcytometry on PB showed 35% monocytes out of which 98.2% classical monocytes (CD14+ CD16-) Fig. 3
and flow on BMA showed 1.2% blast/promonocytes, favouring CMML- 1.
NGS revealed SRSF2 (VAF 51%), KRAS (VAF 22%), TET2 (VAF 83%), PHF6 (VAF 06%)
Final diagnosis – CMML- 1
SRSF2 – most common recurrent mutation in CMML (40-50%), founder driver mutation.
KRAS- 30-40% cases of CMML, worse prognosis and higher risk of transformation to AML
TET2- most frequent mutation in CMML (50-60%), high VAF suggests clonal founder mutation, co-mutation with KRAS worsens prognosis.
PHF6- uncommon in CMML (~2-5%).”
Stay updated with Hemostasis Today.
-
Oct 3, 2025, 07:53Pancytopenia in Pregnancy: A Time-Critical Hematological Emergency
-
Oct 2, 2025, 14:12Helen McPherson at ISFP-IFRS 2025: Fibrin Clot Structure and Function Modulation by Targeting Fibrinogen aC Region
-
Oct 2, 2025, 10:48Kanishk Kumar: TFPI Market Size - Advancing Hemostasis and Antithrombotic Therapy
-
Oct 2, 2025, 07:31Non-Invasive Management of Radial Artery Pseudoaneurysm
-
Oct 2, 2025, 07:28Mohamed Gamal: Rethinking The Standard of Care for Deep Vein Thrombosis Management
-
Oct 3, 2025, 14:00Quentin Van Thillo Shares His Latest Article on VWD: Grateful to Have Worked with Cedric Hermans
-
Oct 3, 2025, 13:40Cihan Ay and Colleagues on Thromboembolism and Bleeding in Multiple Myeloma
-
Oct 3, 2025, 13:27Laura Haynes: This Was Such a Fun and Collaborative Project to Be a Part of!
-
Oct 3, 2025, 12:40Christian Pfrepper and Team's Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
-
Oct 3, 2025, 12:00Giuseppe Lippi and Colleagues on the Impact of Hemolysis on Coagulation Testing
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 3, 2025, 14:48Maha Othman - Elected as the Co-Lead for the Basic and Translational Research Platform at CanVECTOR Research Network
-
Oct 3, 2025, 14:41Maria Elisa Mancuso: A Real Pleasure to Participate in The Policy Roundtable on Future of Haemophilia Care in Egypt
-
Oct 2, 2025, 04:37Louise Bannon: Did You Know that 1 in 4 People Lose Their Lives to Blood Clot-Related Conditions?
-
Oct 1, 2025, 16:35World Thrombosis Day 2025․ 8 Ways to Take Control and Save Lives
-
Oct 1, 2025, 12:30World Stroke Academy "Antithrombotic Therapy for Atherosclerotic Stroke Prevention" Webinar is Now Available to Record